OpenVSafe by OpenVAERS
Search V-safe

ZDG-14966-71063

5 vaccinations 9 coded responses 51 check-ins 7 free-text entries 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
016 / MA
Registered
2021-03-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-29
    Registered in v-safe
  2. 2021-03-29
    Dose 1 — Moderna
  3. 2021-03-29
    Health check-in — day 0, dose 1
    Feeling: Good · Headache
    Adult check-in
  4. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Joint pains
    Adult check-in
  5. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Itching · Fatigue or tiredness
    Adult check-in
  6. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-19
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-04-26
    Dose 2 — Moderna
  14. 2021-04-26
    Survey response — day 0, dose 2
    MedDRA: Dizziness — Feeling: Good · Fatigue or tiredness, Nausea
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Brain fog, Dizziness — Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Dizzy and brain fog
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  17. 2021-04-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  18. 2021-04-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache
    Adult check-in
  19. 2021-05-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Swelling · Headache, Joint pains
    Adult check-in
  20. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · Joint pains, Muscle or body aches
    Adult check-in
  21. 2021-05-03
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-05-10
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-24
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-31
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-07
    Survey response — day 42, dose 2
    MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activities
    Free text: Regular headaches. At least every couple days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-07-26
    Survey response — 3 months, dose 2
    MedDRA: Amenorrhoea, Condition aggravated, Fatigue, Headache, Pre-existing disease, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Congestion, tired, headaches, runny nose, ulcerative colitis flare up, menstruation has stopped.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2021-10-25
    Survey response — 6 months, dose 2
    MedDRA: Colitis ulcerative, Headache, Pre-existing disease, Stress — Feeling: Good · Be unable to work or attend school
    Free text: Ulcerative colitis flare up started in July and lasted to September. May be unrelated to 2nd vax end of April. Having some pretty terrible headaches, but likely stress related on both counts.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-11-01
    Dose 3 — Moderna
  30. 2021-11-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · Joint pains, Fatigue or tiredness
    Adult check-in
  31. 2021-11-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · Joint pains
    Adult check-in
  32. 2021-11-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-11-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-11-08
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-11-15
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-22
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-11-29
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-12-06
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-12-13
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-01-31
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-05-01
    Dose 4 — Moderna
  42. 2022-05-05
    Survey response — 6 months, dose 3
    MedDRA: Tinnitus — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Tinnitis/ear ringing
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-10-11
    Dose 5 — Moderna
  44. 2022-10-11
    Health check-in — day 0, dose 5
    Feeling: Good · None
    Adult check-in
  45. 2022-10-12
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  46. 2022-10-13
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  47. 2022-10-14
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Itching · Fatigue or tiredness
    Adult check-in
  48. 2022-10-16
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  49. 2022-10-17
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  50. 2022-10-18
    Health check-in — day 7, dose 5
    Feeling: Good · Headache, Joint pains
    Adult check-in
  51. 2022-10-25
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  52. 2022-11-01
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  53. 2022-11-08
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  54. 2022-11-15
    Survey response — day 35, dose 5
    MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Good
    Free text: Runny nose, congestion
    MedDRA releases: 2024-11 · check-in free text available
  55. 2022-11-22
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  56. 2023-01-10
    Survey response — 3 months, dose 5
    MedDRA: Influenza — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  57. 2023-01-10
    Report sent to call center — 3 months, dose 5
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  58. 2023-01-11
  59. 2023-04-13
    Survey response — 6 months, dose 5
    MedDRA: Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, Sneezing — Feeling: Good
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-03-29Moderna
22021-04-26Moderna
32021-11-01Moderna No
42022-05-01Moderna No
52022-10-11Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2023-01-10 Unsuccessful

Free text

Release 8 — day 0, dose 2

2021-04-26

Systemic reaction (other): Dizziness

Release 8 — days 1–6 daily, dose 2

2021-04-27

Systemic reaction (other): Dizzy and brain fog

Release 8 — day 42, dose 2

2021-06-07

Symptoms: Regular headaches. At least every couple days

Release 9 — 3 months, dose 2

2021-07-26

Symptoms: Congestion, tired, headaches, runny nose, ulcerative colitis flare up, menstruation has stopped.

Release 10 — 6 months, dose 2

2021-10-25

Symptoms: Ulcerative colitis flare up started in July and lasted to September. May be unrelated to 2nd vax end of April. Having some pretty terrible headaches, but likely stress related on both counts.

Release 11 — 6 months, dose 3

2022-05-05

Symptoms: Tinnitis/ear ringing

Release 12 — day 35, dose 5

2022-11-15

Symptoms: Runny nose, congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAmenorrhoea ✓ · ✓
SDColitis ulcerative · · ✓
SDCondition aggravated ✓ · ✓
SDFatigue ✓ · ✓
SDHeadache ✓ ✓ ✓
SDInfluenza · · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDPre-existing disease ✓ · ✓
SDRespiratory tract congestion ✓ · ✓
SDRhinorrhoea ✓ · ✓
SDSneezing · · ✓
SDStress · · ✓
SDTinnitus · · ✓
SROBrain fog ✓ ✓ ✓
SRODizziness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release